SMITH LEY S 4
4 · TITAN PHARMACEUTICALS INC · Filed Apr 19, 2011
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
SMITH LEY S
Director
Transactions
- Award
Option to Purchase Common Stock
2011-04-15+25,000→ 25,000 totalExercise: $1.40From: 2011-04-15Exp: 2021-04-15→ Common Stock (25,000 underlying) - Award
Option to Purchase Common Stock
2011-04-15+35,000→ 35,000 totalExercise: $1.40Exp: 2021-04-15→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]These options vest in 12 equal monthly installments beginning on the grant date.